Bright Minds Biosciences (DRUG) Stock Chart & Stock Price History → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free DRUG Stock Alerts $1.04 +0.08 (+8.33%) (As of 05/1/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Bright Minds Biosciences Stock Price Performance5 Day Performance-4.55%1 Month Performance-23.92%3 Month Performance-50.94%6 Month Performance-23.36%Year-To-Date Performance-26.58%1 Year Performance-65.67% Receive DRUG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. DRUG Stock Chart for Wednesday, May, 1, 2024 DRUG Chart by TradingView Bright Minds Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/30/2024$1.09$1.00-7.83%$1.13$0.9453,739 shs$4.43 million04/29/2024$1.10$1.09-1.36%$1.13$1.079,872 shs$4.81 million04/26/2024$1.09$1.10+0.92%$1.13$1.056,014 shs$4.87 million04/25/2024$1.09$1.09$1.11$1.0813,063 shs$4.83 million04/24/2024$1.12$1.09-2.68%$1.20$1.093,222 shs$4.83 million04/23/2024$1.12$1.12$1.20$1.113,499 shs$4.97 million Get the Latest News and Ratings for DRUG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/22/2024$1.12$1.12$1.23$1.1118,088 shs$4.96 million04/19/2024$1.18$1.11-5.93%$1.17$1.115,973 shs$4.92 million04/18/2024$1.14$1.18+3.51%$1.21$1.126,723 shs$5.23 million04/17/2024$1.14$1.14$1.22$1.1117,702 shs$5.05 million04/16/2024$1.23$1.14-7.32%$1.32$1.1312,824 shs$5.05 million04/15/2024$1.27$1.23-3.15%$1.30$1.202,330 shs$5.45 million04/12/2024$1.26$1.28+1.60%$1.29$1.2011,246 shs$5.67 million04/11/2024$1.22$1.26+3.27%$1.28$1.2020,344 shs$5.58 million04/10/2024$1.28$1.22-4.69%$1.29$1.202,564 shs$5.41 million04/09/2024$1.21$1.28+5.79%$1.28$1.2013,497 shs$5.67 million04/08/2024$1.17$1.21+3.42%$1.29$1.206,447 shs$5.36 million04/05/2024$1.30$1.17-10.00%$1.30$1.1130,651 shs$5.18 million04/04/2024$1.28$1.30+1.56%$1.38$1.2838,922 shs$5.76 million04/03/2024$1.41$1.28-9.22%$1.41$1.2835,901 shs$5.67 million04/02/2024$1.38$1.41+2.17%$1.45$1.3145,931 shs$6.25 million04/01/2024$1.20$1.38+15.01%$1.38$1.2143,383 shs$6.11 million03/29/2024$1.20$1.20$1.20$1.164,323 shs$5.32 million03/28/2024$1.17$1.20+2.56%$1.20$1.163,223 shs$5.32 million03/27/2024$1.13$1.17+3.54%$1.17$1.1324,090 shs$5.18 million03/26/2024$1.21$1.13-6.61%$1.20$1.0938,218 shs$5.01 million03/25/2024$1.23$1.21-1.63%$1.23$1.1414,164 shs$5.36 million03/22/2024$1.23$1.23$1.25$1.1442,813 shs$5.45 million03/21/2024$1.30$1.23-5.58%$1.31$1.1928,128 shs$5.45 million03/20/2024$1.22$1.30+6.78%$1.30$1.1843,402 shs$5.77 million03/19/2024$1.28$1.22-4.69%$1.26$1.2016,888 shs$5.41 million03/18/2024$1.30$1.28-1.54%$1.30$1.277,566 shs$5.67 million03/15/2024$1.30$1.30$1.37$1.2521,163 shs$5.76 million03/14/2024$1.46$1.30-10.96%$1.47$1.3022,429 shs$5.76 million03/13/2024$1.53$1.46-4.58%$1.58$1.4438,106 shs$6.47 million03/12/2024$1.50$1.53+2.00%$1.59$1.497,871 shs$6.78 million03/11/2024$1.56$1.50-3.85%$1.62$1.4917,651 shs$6.65 million03/08/2024$1.62$1.56-3.41%$1.73$1.4426,455 shs$6.91 million03/07/2024$1.57$1.62+2.87%$1.76$1.5582,851 shs$7.15 million03/06/2024$1.60$1.57-1.88%$1.82$1.5636,485 shs$6.96 millionREAD THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details.03/05/2024$1.71$1.60-6.43%$1.71$1.5712,157 shs$7.09 million03/04/2024$1.76$1.71-2.84%$1.80$1.6212,363 shs$7.58 million03/01/2024$1.80$1.81+0.56%$1.85$1.7611,998 shs$8.02 million02/29/2024$1.81$1.80-0.62%$1.95$1.801,755 shs$7.97 million02/28/2024$1.85$1.81-2.09%$1.90$1.7620,938 shs$8.02 million02/27/2024$1.86$1.85-0.54%$1.97$1.7220,462 shs$8.20 million02/26/2024$1.88$1.86-1.06%$1.93$1.828,693 shs$8.24 million02/23/2024$1.92$1.88-2.08%$1.99$1.8324,869 shs$8.33 million02/22/2024$1.87$1.92+2.94%$2.18$1.9052,174 shs$8.51 million02/21/2024$1.90$1.87-1.84%$1.95$1.8314,284 shs$8.26 million02/20/2024$1.95$1.90-2.56%$2.05$1.8729,437 shs$8.43 million02/19/2024$1.95$1.95$2.04$1.8816,600 shs$8.64 million02/16/2024$1.96$1.95-0.51%$2.04$1.8816,602 shs$8.64 million02/15/2024$1.96$1.96+0.25%$1.96$1.845,553 shs$8.69 million02/14/2024$1.95$1.96+0.26%$2.00$1.8422,273 shs$8.66 million02/13/2024$1.95$1.95$2.00$1.8916,061 shs$8.64 million02/12/2024$1.91$1.95+2.09%$2.02$1.8547,003 shs$8.64 million02/09/2024$1.90$1.91+0.53%$2.02$1.8821,769 shs$8.46 million02/08/2024$2.01$1.90-5.47%$2.03$1.9020,446 shs$8.42 million02/07/2024$2.04$2.01-1.47%$2.13$1.986,154 shs$8.90 million02/06/2024$1.98$2.04+3.03%$2.18$1.8466,230 shs$9.04 million02/05/2024$2.16$1.98-8.33%$2.27$1.9145,987 shs$8.78 million02/02/2024$2.14$2.15+0.47%$2.27$2.0656,294 shs$9.52 million02/01/2024$2.13$2.14+0.47%$2.18$2.0133,742 shs$9.48 million01/31/2024$2.15$2.13-0.93%$2.29$2.0057,947 shs$9.53 million01/30/2024$1.91$2.15+12.86%$2.21$1.9178,962 shs$9.52 million Related Companies: Artelo Biosciences Stock Chart Exicure Stock Chart Petros Pharmaceuticals Stock Chart Ensysce Biosciences Stock Chart Genprex Stock Chart China Pharma Stock Chart Lipella Pharmaceuticals Stock Chart Longeveron Stock Chart Tharimmune Stock Chart NexImmune Stock Chart Receive DRUG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRUG) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlace😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.